Ana Johnson

Senior Adjunct Scientist (Full Status) ICES Queen's Cancer Research Program

Biography

Dr. Ana Johnson came to Queen's University as Canada Research Chair in Health Policy. She is site director of the ICES Queen's Health Services Research Facility, and an associate professor in the Department of Public Health Sciences. Dr. Johnson received her undergraduate training in economics from Nottingham University in England, and her master's in economics from the University of Houston. She completed a PhD in community health sciences (health economics) from the University of Texas, School of Public Health in Houston. Dr. Johnson's research interests have been in economic evaluations of healthcare programs, uncertainty in cost-effectiveness analysis, decision-making, resource allocation, public health, and health technologies. Her recent projects include the economic evaluation of various health programs and analysis of uncertainty in cost-effectiveness analysis using classical and Bayesian methods. Decision analytic projects have concentrated on prioritization and resource allocation in the USA and Canada.

PhD, Health Economics, School of Public Health, University of Texas
MA, Economics, University of Houston
BA, Economics, Nottingham University

Health economics
Healthcare program evaluation
Health services research
Health technology assessment
Health policy/reform

Associate Professor, Department of Public Health Sciences, Queen’s University
Core Faculty, Centre for Health Services and Policy Research at Queen’s University
Member, Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen’s University

ICES Grants

Grant

2019 - 2021

Evaluation of health links in the Southeastern Local Health Integration Network

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Girard P, Hamilton-Kuby CD, Huras PW, Johnson A
Co-Investigators: Donnelly CA, Egan RG, Green ME, Parlow JL, Tenbensel TG
Grant Type: Operating Grant
Grant Amount: $199,905

Grant

2015 - 2016

Neonatal abstinence syndrome in Ontario

Granting Agency: Senate Advisory Research Committee (SARC) Queen's University
Principal Investigators: Brogly S
Co-Investigators: Johnson A
Grant Type: Senate Advisory Research Committee (SARC) Grant
Grant Amount: $10,000

Grant

2014 - 2016

Thoracic aortic disease in Canada – incidence, prevalence and economic burden: an epidemiologic analysis

Granting Agency: Kingston General Hospital, Department of Surgery, Departmental Development and Innovation Fund
Principal Investigators: McClure RS, Johnson A
Grant Type: Internal Grant
Grant Amount: $24,728

Grant

2013 - 2016

Evaluation of blood product utilization, healthcare resource consumption and patient outcomes in new oral anticoagulant-related hemorrhage

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Johnson A, Dowlatshahi D, Schulman S
Co-Investigators: Giulivi A, Heddle N, Holbrook A, Simpson C, Wells P, Xu Y
Grant Type: Operating Grant
Grant Amount: $304,604

Grant

2013 - 2016

Evaluation of healthcare utilization and outcomes for new oral anticoagulant-related hemorrhage in the elderly: a population-based cohort study

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Johnson A
Grant Type: Operating Grant
Grant Amount: $302,673

Grant

2013 - 2014

Geographical pattern of statins’ prescription and use before and after patent expiration for high potency statins (Lipitor and Crestor) amongst elderly patients with diabetes in Ontario according to socioeconomic and gender strata and its impact on healthcare utilization/cost

Granting Agency: Queen's Department of Medicine Innovation Fund
Principal Investigators: Farahani P
Co-Investigators: Johnson A
Grant Type: Innovation Fund
Grant Amount: $20,000

Grant

2012 - 2015

A population-based outcome and economic evaluation of interventions for gastric cancer

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Coburn N, Johnson A
Co-Investigators: Krahn M, Law C, Irish J, Mcleod R, Brar S, Dixon M, Dobrow M, Earle C, Karanicolas P, Kiss A, Mahar A, Paszat L, Wright F, Kiss A
Grant Type: Operating Grant
Grant Amount: $288,133

See All

Awards & Recognition

01/07/2005

Canada Research Chair in Health Policy

2005 — Awarded to Dr. Ana Johnson for a 5 year term.

See All

Journal Articles

Journal Article

04/07/2024

Carotid plaque score is associated with 10-year major adverse cardiovascular events in low-intermediate risk patients referred to a general cardiology community clinic

Matangi MF, Hétu MF, Armstrong DWJ, Shellenberger J, Brouillard D, Baker J, Johnson A, Grubic N, Willms H, Johri AM. Eur Heart J Cardiovasc Imaging. 2024; Jul 4 [Epub ahead of print].

Journal Article

26/06/2024

Postdischarge opioid use after lumbar spine surgery among older adults in Ontario: a population-based cohort study

Johnson A, Nguyen F, Richardson M, Rabi S, Mann S, Gilron I, Yach J, Milne B, Evans G, Parlow J. Can J Surg. 2024; 67(3):E252-E260. Epub 2024 Jun 26.

Journal Article

22/03/2022

Chronic opioid use after joint replacement surgery in seniors is associated with increased healthcare utilization and costs: a historical cohort study

Johnson A, Milne B, Jamali N, Pasquali M, Gilron I, Mann S, Moore K, Graves E, Parlow J. Can J Anaesth. 2022; 69(8):963-73. Epub 2022 Mar 22.

Journal Article

23/02/2022

Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study

Xu Y, Gomes T, Wells PS, Pequeno P, Johnson A, Sholzberg M. Thromb Res. 2022; 213:57-64. Epub 2022 Feb 23.

Journal Article

25/08/2021

Long-term opioid use in seniors following hip and knee arthroplasty in Ontario: a historical cohort study

Johnson A, Milne B, Pasquali M, Jamali N, Mann S, Gilron I, Moore K, Graves E, Parlow J. Can J Anaesth. 2021; 69(8):934-44. Epub 2021 Aug 25.

Journal Article

27/05/2020

Economic burden and healthcare resource use for thoracic aortic dissections and thoracic aortic aneurysms—a population‐based cost‐of‐illness analysis

McClure RS, Brogly SB, Lajkosz K, McClintock C, Payne D, Smith HN, Johnson AP. J Am Heart Assoc. 2020; 9(11):e014981. Epub 2020 May 27.

Journal Article

17/10/2019

Potential impact of changes in administrative database coding methodology on research and policy decisions: an example from the Ontario Health Insurance Plan

Johnson AP, Milne B, Whitehead M, Xu J, Parlow JL. Can J Anaesth. 2020; 67(4):487-8. Epub 2019 Oct 17.

Journal Article

23/09/2019

Use of instrumented lumbar spinal surgery for degenerative conditions: trends and costs over time in Ontario, Canada

Xu Y, Yen D, Whitehead M, Xu J, Johnson AP. Can J Surg. 2019; 62(6):017016. Epub 2019 Sep 23.

Journal Article

02/08/2019

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M, Frymire E, Khan S, Johnson AP; Bleeding Effected by Direct Oral Anticoagulants (BLED-AC) Study Group. Thromb Res. 2019; 182:12-9. Epub 2019 Aug 2.

Journal Article

14/02/2018

Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada

Wijeratne TD, Lajkosz K, Brogly SB, Loughheed MD, Jiang L, Housin A, Barber D, Johnson A, Doliszny KM, Archer SL. Circ Cardiovasc Qual Outcomes. 2018; 11(2):e003973. Epub 2018 Feb 14.

See All

Contact Details

Get in touch with
Ana Johnson

"*" indicates required fields

Ana Johnson

Biography

Education

Research Focus

Other Affiliations

ICES Grants

Evaluation of health links in the Southeastern Local Health Integration Network

Neonatal abstinence syndrome in Ontario

Thoracic aortic disease in Canada – incidence, prevalence and economic burden: an epidemiologic analysis

Evaluation of blood product utilization, healthcare resource consumption and patient outcomes in new oral anticoagulant-related hemorrhage

Evaluation of healthcare utilization and outcomes for new oral anticoagulant-related hemorrhage in the elderly: a population-based cohort study

Geographical pattern of statins’ prescription and use before and after patent expiration for high potency statins (Lipitor and Crestor) amongst elderly patients with diabetes in Ontario according to socioeconomic and gender strata and its impact on healthcare utilization/cost

A population-based outcome and economic evaluation of interventions for gastric cancer

Awards & Recognition

Canada Research Chair in Health Policy

Journal Articles

Carotid plaque score is associated with 10-year major adverse cardiovascular events in low-intermediate risk patients referred to a general cardiology community clinic

Postdischarge opioid use after lumbar spine surgery among older adults in Ontario: a population-based cohort study

Chronic opioid use after joint replacement surgery in seniors is associated with increased healthcare utilization and costs: a historical cohort study

Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study

Long-term opioid use in seniors following hip and knee arthroplasty in Ontario: a historical cohort study

Economic burden and healthcare resource use for thoracic aortic dissections and thoracic aortic aneurysms—a population‐based cost‐of‐illness analysis

Potential impact of changes in administrative database coding methodology on research and policy decisions: an example from the Ontario Health Insurance Plan

Use of instrumented lumbar spinal surgery for degenerative conditions: trends and costs over time in Ontario, Canada

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada

Get in touch with
Ana Johnson

Ana Johnson

Biography

Education

Research Focus

Other Affiliations

ICES Grants

Evaluation of health links in the Southeastern Local Health Integration Network

Neonatal abstinence syndrome in Ontario

Thoracic aortic disease in Canada – incidence, prevalence and economic burden: an epidemiologic analysis

Evaluation of blood product utilization, healthcare resource consumption and patient outcomes in new oral anticoagulant-related hemorrhage

Evaluation of healthcare utilization and outcomes for new oral anticoagulant-related hemorrhage in the elderly: a population-based cohort study

Geographical pattern of statins’ prescription and use before and after patent expiration for high potency statins (Lipitor and Crestor) amongst elderly patients with diabetes in Ontario according to socioeconomic and gender strata and its impact on healthcare utilization/cost

A population-based outcome and economic evaluation of interventions for gastric cancer

Awards & Recognition

Canada Research Chair in Health Policy

Journal Articles

Carotid plaque score is associated with 10-year major adverse cardiovascular events in low-intermediate risk patients referred to a general cardiology community clinic

Postdischarge opioid use after lumbar spine surgery among older adults in Ontario: a population-based cohort study

Chronic opioid use after joint replacement surgery in seniors is associated with increased healthcare utilization and costs: a historical cohort study

Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study

Long-term opioid use in seniors following hip and knee arthroplasty in Ontario: a historical cohort study

Economic burden and healthcare resource use for thoracic aortic dissections and thoracic aortic aneurysms—a population‐based cost‐of‐illness analysis

Potential impact of changes in administrative database coding methodology on research and policy decisions: an example from the Ontario Health Insurance Plan

Use of instrumented lumbar spinal surgery for degenerative conditions: trends and costs over time in Ontario, Canada

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada

Get in touch with Ana Johnson

Get in touch with
Ana Johnson